ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

Karolinska University Hospital at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Karolinska University Hospital takes part in 7 sessions at ESMO 2026 in Madrid. Its program spans melanoma, bladder, breast and lung cancer, with a focus on treatment strategies. It examines pembrolizumab-based treatment before and after surgery for muscle-invasive bladder cancer.

OrganizationESMO 2026 Attendance
Cancer centre & hospital
University hospital of the Karolinska Institutet medical university in Stockholm, Sweden.
Chair
Sat Oct 24
10:15–11:45
Beyond guidelines: Expert navigation through the grey zones of oncology practice
with Fondazione IRCCS Istituto Nazionale dei Tumori
Poster
Sun Oct 25
12:00–12:45
Loss of GATA-3 expression defines a distinct nuclear morphometric phenotype associated with tumour dedifferentiation in breast cancer
Sunday Poster Display session 2
Breast cancerBiomarkers & precision oncology
Talk
Mon Oct 26
08:45–09:00
BITE and immune checkpoints
Advancing targeted and immunotherapeutic strategies in upper GI cancer
Gastrointestinal cancers
Abstract
Mon Oct 26
09:34–09:46
Invited Discussant LBA71 and LBA72
Proffered paper 2: NSCLC, metastatic
Lung & thoracic cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Karolinska University Hospital

Tell us what you sell and we’ll find the people at Karolinska University Hospital most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction